tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $-2.52. This is a potential upside of $-10.17 (-132.94%) from yesterday's end of day stock price of $7.65.
LogicBio Therapeutics's activity chart (see below) currently has 1 price targets and 5 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 174.75 days.
Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 21-Aug-2022. First documented stock forecast 01-May-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
3 years 2 months 5 days ago
(21-Aug-2022)
1/1 (100%)
$-61.4 (-79.33%)
320
Buy
$2
$-5.93 (-74.78%)
$16
3 years 5 months 16 days ago
(10-May-2022)
3/3 (100%)
$1.54 (334.78%)
379
Buy
$8
$5.93 (286.47%)
3 years 11 months 9 days ago
(17-Nov-2021)
0/1 (0%)
$4.53 (130.55%)
Buy
$26
$23.93 (1156.04%)
$26
5 years 9 months 16 days ago
(10-Jan-2020)
0/3 (0%)
$14.67 (150.78%)
What is LOGC (LogicBio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the current lower performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most bullish on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most reserved on LOGC (LogicBio Therapeutics)?
